ArticleBMC cancer2014

Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability.

Jenny Brändstedt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.